Finckenstein Friedrich Graf Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Finckenstein Friedrich Graf is Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 111,656 shares of IOVA, which is worth approximately $275,790. The most recent transaction as insider was on Dec 02, 2025, when has been sold 1,984 shares (Common Stock) at a price of $2.14 per share, resulting in proceeds of $4,245. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 112K

5.93% 3M change

78.22% 12M change

Total Value Held $275,790

FINCKENSTEIN FRIEDRICH GRAF Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Payment of exercise price or tax liability	$4,245 $2.14 p/Share	1,984 Reduced 1.75%	111,656 Common Stock
Dec 02 2025	BUY Exercise of conversion of derivative security	-	3,906 Added 3.32%	113,640 Common Stock
Dec 01 2025	SELL Payment of exercise price or tax liability	$9,954 $2.23 p/Share	4,464 Reduced 3.91%	109,734 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	8,789 Added 7.15%	114,198 Common Stock
Sep 02 2025	SELL Payment of exercise price or tax liability	$14,121 $2.19 p/Share	6,448 Reduced 5.76%	105,409 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	-	12,697 Added 10.19%	111,857 Common Stock
Jun 02 2025	SELL Payment of exercise price or tax liability	$11,348 $1.76 p/Share	6,448 Reduced 6.11%	99,160 Common Stock

Jun 02 2025	BUY Exercise of conversion of derivative security	-	12,695 Added 10.73%	105,608 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$135,218 $4.04 p/Share	33,470 Reduced 26.48%	92,913 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	62,497 Added 33.09%	126,383 Common Stock
Jan 14 2025	SELL Payment of exercise price or tax liability	$9,294 $5.89 p/Share	1,578 Reduced 2.41%	63,886 Common Stock
Jan 14 2025	BUY Exercise of conversion of derivative security	-	2,813 Added 4.12%	65,464 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$17,976 $9.07 p/Share	1,982 Reduced 3.07%	62,651 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	-	3,906 Added 5.7%	64,633 Common Stock
Oct 14 2024	SELL Payment of exercise price or tax liability	$13,951 $9.77 p/Share	1,428 Reduced 2.3%	60,727 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 4.33%	62,155 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$150,532 $10.85 p/Share	13,874 Reduced 18.95%	59,342 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	27,345 Added 27.74%	71,233 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$12,395 $8.68 p/Share	1,428 Reduced 3.02%	45,871 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 5.61%	47,299 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$16,589 $8.37 p/Share	1,982 Reduced 4.27%	44,486 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	-	3,906 Added 7.75%	46,468 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$16,967 $11.89 p/Share	1,427 Reduced 3.24%	42,562 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	2,812 Added 6.01%	43,989 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$136,578 $16.96 p/Share	8,053 Reduced 16.36%	41,177 Common Stock

FFG

Finckenstein Friedrich Graf

Chief Medical Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account